Capital Performance Advisors LLP Biotechnology

Capital Performance Advisors LLP

$325 Million
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VNDA Vanda Pharmaceuticals Inc.	$274M	$1,000 0.0% of portfolio	303	Q3 2024 New
CAPR Capricor Therapeutics, Inc.	$354M	$1,000 0.0% of portfolio	91	Q3 2024 New
CDXS Codexis, Inc.	$327M	$1,000 0.0% of portfolio	514	Q3 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$1,000 0.0% of portfolio	412	Q3 2024 New
CRSP Crispr Therapeutics Ag	$3.27B	$1,000 0.0% of portfolio	42	Q3 2024 New
URGN Uro Gen Pharma Ltd.	$252M	$1,000 0.0% of portfolio	138	Q3 2024 New
DNLI Denali Therapeutics Inc.	$2.84B	$1,000 0.0% of portfolio	63	Q3 2024 New
ALEC Alector, Inc.	$163M	$1,000 0.0% of portfolio	243	Q3 2024 New
RPRX Royalty Pharma PLC	$11.4B	$1,000 0.0% of portfolio	43	Q3 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$796M	$1,000 0.0% of portfolio	141	Q3 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$911M	$1,000 0.0% of portfolio	80	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$114M	$1,000 0.0% of portfolio	675	Q3 2024 New
TRDA Entrada Therapeutics, Inc.	$541M	$1,000 0.0% of portfolio	71	Q3 2024 New
ABSI Absci Corp	$285M	$0 0.0% of portfolio	11	Q3 2024 New
RAPT Rapt Therapeutics, Inc.	$47.5M	$0 0.0% of portfolio	34	Q3 2024 New
NKTR Nektar Therapeutics	$223M	$0 0.0% of portfolio	66	Q3 2024 New
CDMO Avid Bioservices, Inc.	$768M	$0 0.0% of portfolio	80	Q3 2024 New
ACAD Acadia Pharmaceuticals Inc	$2.81B	$0 0.0% of portfolio	25	Q3 2024 New
VCEL Vericel Corp	$2.74B	$0 0.0% of portfolio	7	Q3 2024 New
GERN Geron Corp	$1.28B	$0 0.0% of portfolio	152	Q3 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$176M	$0 0.0% of portfolio	18	Q3 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$98.5M	$0 0.0% of portfolio	163	Q3 2024 New
TGTX Tg Therapeutics, Inc.	$4.07B	$0 0.0% of portfolio	23	Q3 2024 New
MNKD Mannkind Corp	$1.61B	$0 0.0% of portfolio	129	Q3 2024 New
NVAX Novavax Inc	$846M	$0 0.0% of portfolio	41	Q3 2024 New
XOMA Xoma Corp	$294M	$0 0.0% of portfolio	25	Q3 2024 New
SGMO Sangamo Therapeutics, Inc	$214M	$0 0.0% of portfolio	200	Q3 2024 New
INVA Innoviva, Inc.	$1.2B	$0 0.0% of portfolio	31	Q3 2024 New
CYTK Cytokinetics Inc	$4.57B	$0 0.0% of portfolio	8	Q3 2024 New
FENC Fennec Pharmaceuticals Inc.	$158M	$0 0.0% of portfolio	5	Q3 2024 New
VERU Veru Inc.	$59.3M	$0 0.0% of portfolio	124	Q3 2024 New
ALT Altimmune, Inc.	$358M	$0 0.0% of portfolio	11	Q3 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.53B	$0 0.0% of portfolio	3	Q3 2024 New
AVXL Anavex Life Sciences Corp.	$1.05B	$0 0.0% of portfolio	135	Q3 2024 New
FOLD Amicus Therapeutics, Inc.	$2.63B	$0 0.0% of portfolio	43	Q3 2024 New
OMER Omeros Corp	$638M	$0 0.0% of portfolio	36	Q3 2024 New
CRMD Cor Medix Inc.	$327M	$0 0.0% of portfolio	47	Q3 2024 New
IOVA Iovance Biotherapeutics, Inc.	$1.17B	$0 0.0% of portfolio	11	Q3 2024 New
PYXS Pyxis Oncology, Inc.	$61.1M	$0 0.0% of portfolio	142	Q3 2024 New
PBYI Puma Biotechnology, Inc.	$177M	$0 0.0% of portfolio	15	Q3 2024 New
ATOS Atossa Therapeutics, Inc.	$122M	$0 0.0% of portfolio	25	Q3 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$36.5M	$0 0.0% of portfolio	437	Q3 2024 New
ENTA Enanta Pharmaceuticals Inc	$112M	$0 0.0% of portfolio	63	Q3 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	85	Q3 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$554M	$0 0.0% of portfolio	2	Q3 2024 New
BLUE Bluebird Bio, Inc.	$696M	$0 0.0% of portfolio	173	Q3 2024 New
PGEN Precigen, Inc.	$275M	$0 0.0% of portfolio	2	Q3 2024 New
FATE Fate Therapeutics Inc	$170M	$0 0.0% of portfolio	90	Q3 2024 New
XNCR Xencor Inc	$1.43B	$0 0.0% of portfolio	3	Q3 2024 New
AKBA Akebia Therapeutics, Inc.	$346M	$0 0.0% of portfolio	68	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.